Cooley Represents Trius Therapeutics in Acquisition by Cubist Pharmaceuticals

San Diego, Calif. – August 5, 2013 – Cooley LLP announced today that it represented Trius Therapeutics in its acquisition by Cubist Pharmaceuticals. The total transaction is valued at up to $818 million. 

Trius is a San Diego-based biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. Cubist is a bio-pharmaceutical company focused on the research, commercialization and creation of pharmaceutical products that address unmet medical needs in the acute care environment.

The Cooley transaction team was led by partners Charles Bair and Barbara Borden, who heads the firm's M&A practice, and included special counsel Rama Padmanabhan, and partners Thomas Welk (Compensation & Benefits) and Jackie Grise (Antitrust). Associates Wade Andrews, Holly Attiq, Daniel Gutierrez, Kevin Henderson, Justin Ho and Matt Robbins also provided critical support on the deal.

Cooley, which has been general outside corporate counsel to Trius since its inception in 2004, also advised the company on its 2010 initial public offering and on a series of subsequent financings.

About Cooley LLP

Cooley's 700 attorneys have an entrepreneurial spirit and deep, substantive experience, and are committed to solving clients' most challenging legal matters. From small companies with big ideas to international enterprises with diverse legal needs, Cooley has the breadth of legal resources to enable companies of all sizes to seize opportunities in today's global marketplace. The firm represents clients across a broad array of dynamic industry sectors, including technology, life sciences, health care, venture capital, clean energy, real estate and retail.

The firm has full-service offices in eleven major business and technology centers: Boston, MA; Broomfield, CO; Los Angeles, CA; New York, NY; Palo Alto, CA; Reston, VA; San Diego, CA; San Francisco, CA; Seattle, WA; Washington, DC; and Shanghai, China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.